Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nightstar Therapeutics Plc ADR (NITE)

Nightstar Therapeutics Plc ADR (NITE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nightstar Therapeutics Plc ADR 10 MIDFORD PLACE 2ND FLOOR LONDON X0 W1T5BJ GBR

P: 44-20-7062-2777

Description:

Nightstar Therapeutics Limited is a clinical-stage gene therapy company. It focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy. The company operates primarily in North America and Europe. Nightstar Therapeutics Limited is based in LONDON, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 852,150
Shares Outstanding, K 33,536
Annual Sales, $ 0 K
Annual Net Income, $ -36,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,390 K
60-Month Beta 2.87
% of Institutional Shareholders 32.83%
Float, K 33,536
% Float 100.00%

Growth:

1-Year Return 78.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 06/05/19
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Year 3.85%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

NITE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -11.49
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -30.89
Return-on-Assets (Before Tax) -27.65
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.68
Book Value/Share 4.47
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar